Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy

Journal of Neuroimmunology

Volumn 75, Issue 1-2, 1997, Pages 141-146

  Inoue, Atsushi ^a   Koh, Chang Sung ^a   Sakai, Toshiaki ^a   Yamazaki, Masashi ^a   Yanagisawa, Nobuo ^a   Usuku, Koichiro ^b   Osame, Mitsuhiro ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Fas; human T lymphotropic virus type I associated myelopathy; multiple sclerosis

Indexed keywords

FAS ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SPINAL CORD DISEASE;

ADULT; AGED; ANTIGENS, CD95; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PARAPARESIS, TROPICAL SPASTIC; SOLUBILITY;

EID: 0030996690     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00012-X     Document Type: Article

References (31)

1. Adachi, M., Watanabe-Fukunaga, R. and Nagata, S. (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90, 1756-1760.
2. Cheng, J., Zhou, T., Liu, C., Shapiro, J.P., Brauer, M.J., Kiefer, M.C., Barr, P.J. and Mountz, J.D. (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759-1762.
3. Debatin, K.-M., Goldman, C.K., Bamford, R., Waldmann, T.A. and Krammer, P.H. (1990) Monoclonal - antibody-mediated apoptosis in adult T-cell leukemia. Lancet 335, 497-500.
4. Dhein, J., Walczac, H., Baumier, C., Debatin, K.M. and Krammer, P.H. (1995) Autocrine T-cell suicide mediated by APO-1(Fas/CD95). Nature 373, 438-441.
5. Elovaara, I., Koenig, S., Brewah, A.Y., Woods, R.M., Lehky, T. and Jacobson, S. (1993) High human T cell lymphotropic virus type I (HTLV-I)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-I associated neurological disease. J. Exp. Med. 177, 1567-1573.
6. Falk, M.H., Trauth, B.C., Debatin, K.-M., Klas, C., Gregory, C.D., Rickinson, A.B., Calendar, A., Lenoir, G.M., Elliwart, J.W., Krammer, P.H. and Bornkamm, G.W. (1992) Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 79, 3300-3306.
7. Hara, H., Morita, M., Iwaki, T., Hatase, T., Itoyama, Y., Kitamoto, T., Akizuki, S., Goto, I. and Watanabe, T. (1994) Detection of human T lymphotropic virus type I (HTLV-I) provial DNA and analysis of T cell receptor Vb CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Exp. Med. 180, 831-839.
8. Ito, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
9. Ju, S.-T., Panka, D.J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D.H., Stanger, B.Z. and Marshak-Rothstein, A. (1995) Fas (CD95)/Fas L interactions required for programmed cell death after T-cell activation. Nature 373, 444-448.
10. Kägi, D., Vignaux, F., Ledermann, B., Bürki, K., Deparaetere, V., Nagata, S., Hengartner, H. and Goldstein, P. (1994) Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265, 528-530.
11. Kira, J., Nakamura, M., Sawada, T., Koyanagi, Y., Ohori, N., Itoyama, Y., Yamamoto, N., Sakaki, Y. and Goto, I. (1992) Antibody titers to HTLV-I-p40 tax protein and gag-env hybrid protein HTLVI-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I provial DNA load. J. Neurol. Sci. 107, 98-104.
12. Lehky, T.J., Fox, C.H., Koenig, S., Levin, M.C., Flerlage, N., Izumo, S., Sato, E., Raine, C.S., Osame, M. and Jacobson, S. (1995) Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann. Neurol. 37, 167-175.
13. Lowin, B., Hahne, M., Mattmann, C. and Tschopp, J. (1994) Cytolytic T cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370, 650-652.
14. + T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J. Neurol. Sci. 139, 1-6.
15. Nagata, S. and Goldstein, P. (1995) The Fas death factor. Science 267, 1449-1456.
16. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., Trauth, B.C., Ponstingi, H. and Krammer, P.H. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267, 10709-10715.
17. Okubo, M., Ishida, H. and Kasukawa, R. (1996) Elevated lebels of soluble Fas in systemic lupus erythematosus (letter). Arthritis Rheum 39, 1612-1613.
18. Osame, M., Matsumoto, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Tara., M. and Igata, A. (1987) Chronic progressive myelopathy associated with elevated antibodies to human Tlymphotropic virus type I and adult T-cell leukemia like cells. Ann. Neurol. 21, 117-122.
19. Pender, M.P., Nguyen, K.B., McCombe, P.A. and Kerr, J.F. (1991) Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci., 104, 81-87.
20. Pender, M.P., McCombe, P.A., Yoong, G. and Nguyen, K.B. (1992) Apoptosis of αβ T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acqired tolerance. J. Autoimmun. 5, 401-410.
21. Poser, C.M., Paty, D.W., Sceinberg, L., McDonald, I., Davis, F.A., Ebers, G.C., Johnson, K.P., Sibley, W.A., Silberberg, D.H. and Tourtellotte, W.W. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227-231.
22. Seishima, M., Takemura, M., Saito, K., Sano, H., Minatoguchi, S., Fujiwara, H., Hachiya T. and Noma, A. (1996) Highly sensitive enzyme-linked immunosorbent assay for soluble Fas: Elevation of soluble Fas in the elderly. Clin. Chem. 42, 1911-1914.
23. Smith, C.A., Farrah, T. and Goodwin, R.G. (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76, 959-962.
24. Suda, T., Takahashi, T., Goldstein, P. and Nagata, S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the TNF family. Cell 75, 1169-1178.
25. Suda, T. and Nagata, S. (1994) Purification and characterization of the Fas ligand that induces apoptosis. J. Exp. Med. 179, 873-879.
26. Tabira, T., Inobe, J., Nakahara, K., Osame, M. and Yamamura, T. (1994) Suppression of lymphocyte spontaneous proliferative response by proteolipid protein peptide in patients with HAM/TSP. Neurochem. Res. 19, 1067-1071.
27. Takahashi, T., Tanaka, M., Brannan, C.I. Jenkins, N.A., Copeland N.G., Suda, T. and Nagata, S. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
28. Takizawa, T., Matsukawa, S., Higuchi, Y., Nakamura, S., Nakanishi, Y. and Fukuda, R. (1993) Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J. Gen. Virol. 74, 2747-2755.
29. Trauth, B.C., Klaus, C., Peters, A.M.J., Matzku, S., Moller, P., Falk, W. Debatin, K.-M. and Krammer, P.M. (1989) Monoclonal antibody-mediated tumor regression by induction apoptosis. Science 245, 301-305.
30. Uehara, T., Miyawaki, T., Ohta, K., Tamaru, Y., Yokoi, T., Nakamura, S. and Tanigutchi, N. (1992) Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood 80, 452-458.
31. Yonehara, S., Ishii, A.M. and Yonehara, A. (1989) Cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.